|
|||||
|
|
Enantiomeric drug development: issues, considerations, and regulatory requirements. |
|
| Authors: | N R Srinivas R H Barbhaiya K K Midha |
| Affiliation: | Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA. |
| Abstract: | |
| Keywords: | |